1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol
C26H39FN6O3 — CID 118881298
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol
1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol (PubChem CID 118881298) has the molecular formula C26H39FN6O3 and a molecular weight of 502.64 g/mol. Its IUPAC name is 1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol.
Molecular Properties
| Compound Name | 1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol |
|---|---|
| PubChem CID | 118881298 |
| Molecular Formula | C26H39FN6O3 |
| Molecular Weight | 502.64 g/mol |
| Exact Mass | 502.31 |
| IUPAC Name | 1-[3-[4-[4-(2-fluoroethyl)piperazin-1-yl]-6-[methyl(oxan-4-yl)amino]pyrimidin-2-yl]phenoxy]-3-(methylamino)propan-2-ol |
| SMILES | CNCC(O)COc1cccc(-c2nc(N3CCN(CCF)CC3)cc(N(C)C3CCOCC3)n2)c1 |
| InChI | InChI=1S/C26H39FN6O3/c1-28-18-22(34)19-36-23-5-3-4-20(16-23)26-29-24(31(2)21-6-14-35-15-7-21)17-25(30-26)33-12-10-32(9-8-27)11-13-33/h3-5,16-17,21-22,28,34H,6-15,18-19H2,1-2H3 |
| InChIKey | SWQBLFVBPREKBT-UHFFFAOYSA-N |
| XLogP | 1.81 |
| TPSA | 86.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.64 |
| LogP ≤ 5 | 1.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118881298 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.